Interleukin 6 gene promoter polymorphism is not associated with ankylosing spondylitis

Journal of Rheumatology

Volumn 27, Issue 6, 2000, Pages 1461-1463

  Collado Escobar, Maria Dolores ^a   Nieto, Antonio ^a   Matarán, Luis ^b   Raya, Enrique ^c   Martín, Javier ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

Ankylosing spondylitis; HLA B27; Interleukin 6; Polymorphism

Indexed keywords

INTERLEUKIN 6;

ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLELES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-B27 ANTIGEN; HUMANS; INTERLEUKIN-6; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SPAIN; SPONDYLITIS, ANKYLOSING;

EID: 0034123190     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. van der Linden SM, Valkenburg HA, de Jongh B, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984;3:241-9.
2. Rubin LA, Amos CI, Wade JA, et al. Investigating the genetic basis for ankylosing spondylitis. Arthritis Rheum 1994;37:1212-20.
3. Brown MA, Kennedy LG, MacGregor AJ, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997;40:1823-8.
4. Van Snick J. Interleukin-6: an overview. Ann Rev Immunol 1990;8:253-78.
5. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspect of interleukin 6. Immunol Today 1990;11:443-9.
6. Gratacos J, Collado A, Filella X, et al. Serum cytokines (IL-6, TNF α, IL-1β and IFN-γ) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 1994;33:927-31.
7. Falkenbach A, Herold M. In ankylosing spondylitis serum interleukin-6 correlates with the degree of mobility restriction, but not with short term changes in the variables of mobility. Rheumatol Int 1998;18: 103-6.
8. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-76.
9. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1994;27:361-8.
10. Pascual M, Nieto A. Matarán L, Martín J. IL-6 promoter polymorphism in rheumatoid arthritis. Genes Immun 2000; (in press).
11. Tiwari JL, Terasaki PI. HLA and disease associations. New York: Springer-Verlag; 1985.
12. Hohler T, Schaper T, Scheneider PM, Meyer zum Buschenfelde K-H, Marker-Herman E. Association of different tumor necrosis factor α promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum 1998;41:1489-92.
13. Bowcock AM, Kidd JR, Lathrop M, et al. The human "beta-2 interferon/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics 1988;3:8-16.
14. Fugger L, Morling N, Bendtzen K, et al. MspI polymorphism in the human interleukin 6 gene. Nucleic Acids Res 1989;17:4419.
15. Fugger L, Morling N, Bendtzen K, Ryder L, Svejgaard A. Bg/II polymorphism in the human interleukin 6 gene. Nucleic Acids Res 1989;17:7548.